688373 盟科药业
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-12.963-41.120-26.660-42.749-30.320
总资产报酬率 ROA (%)-8.992-31.593-20.532-34.349-23.403
投入资产回报率 ROIC (%)-9.994-33.692-21.557-37.106-26.955

边际利润分析
销售毛利率 (%)82.40481.60881.69992.449--
营业利润率 (%)-309.336-452.655-462.460-3,343.976--
息税前利润/营业总收入 (%)-300.640-448.462-435.981-2,911.436--
净利润/营业总收入 (%)-309.354-463.914-456.987-2,953.915--

收益指标分析
经营活动净收益/利润总额(%)105.261107.841121.401120.365112.284
价值变动净收益/利润总额(%)-5.182-8.032-8.394-4.6540.163
营业外收支净额/利润总额(%)0.0061.024-1.200-13.224-12.172

偿债能力分析
流动比率 (X)7.1967.71511.9065.41019.930
速动比率 (X)6.9437.44111.7165.29319.761
资产负债率 (%)32.75728.63018.90632.4067.283
带息债务/全部投入资本 (%)16.83413.1129.1547.511-2.499
股东权益/带息债务 (%)445.702602.728918.363973.704-4,001.456
股东权益/负债合计 (%)205.274249.282428.927208.5831,273.134
利息保障倍数 (X)-34.502-50.535-20.766-69.367-58.129

营运能力分析
应收账款周转天数 (天)65.88365.59546.74566.585--
存货周转天数 (天)560.793640.488671.2095,171.330--